Literature DB >> 23573352

Effect of bone marrow transplantation on diastolic function indices.

Mersedeh Karvandi1, Mohammad Asadpour Piranfar, Shahrooz Yazdani, Mahshid Mehdizadeh, Abbas Hajfathali, Mehdi Tabarraee.   

Abstract

INTRODUCTION: High-dose chemotherapy and bone marrow transplantation result in direct and indirect changes in cardiac function. the finding suggests a decreased left ventricular diastolic compliance after high-dose cyclophosphamide treatment, but the effects of bone marrow transplantation (BMT) on cardiac diastolic function are less studied. We aimed to evaluate changes before and after the procedure in cardiac diastolic function in patients undergoing BMT. DESIGN AND METHODS: We designed this study to evaluate the effects of BMT on diastolic cardiac function. Patients with lymphoma (Hodgkin's and non-Hodgkin's), multiple myeloma, and solid tumors who were candidates for autologous BMT were selected for the study. The patients underwent a cardiac consultation and echocardiography before their admission for BMT. E-wave velocity and time to relaxation by tissue Doppler echocardiography in the septal, lateral, anterior, inferior, anteroseptal, and posterior wall; and the E-wave velocity of the right ventricle (RV) were measured before and after BMT. RESULT: Thirty patients fulfilled our inclusion criteria and entered the study. The mean diastolic function measures were calculated before and after BMT. E-wave velocity in the septal, lateral, anterior, inferior, anteroseptal and posterior walls after transplantation decreased by 19.2% (p=0.008), 14.5% (p=0.008), 22.19% (p=0.3), 18.9% (p<0.001), 21.9% (p=0.01), and 7.5% (p=0.01), respectively. The time to relaxation decreased by 13.5%, 13.7%, 12.4%, 11.4%, 11.1%, and 13.1%, respectively, after transplantation (p<0.001). E-wave velocity of RV decreased 15.6% after BMT (p=0.02).
CONCLUSION: Data regarding alterations in diastolic functioning after BMT are scarce. This study suggests that diastolic function alters after BMT.

Entities:  

Keywords:  Bone marrow transplantation; echocardiography; tissue Doppler

Year:  2013        PMID: 23573352      PMCID: PMC3609697     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  14 in total

Review 1.  Evaluation and management of diastolic heart failure.

Authors:  Brad G Angeja; William Grossman
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

2.  [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].

Authors:  L Elbl; I Vásová; M Krejcí; M Navrátil; I Tomásková; F Jedlicka; V Chaloupka; J Mayer; J Vorlícek
Journal:  Vnitr Lek       Date:  2006-03

3.  Acute systolic dysfunction within two weeks of high-dose chemotherapy conditioning before autologous bone marrow transplant: a case report.

Authors:  Raghav Gupta; Christina Murray; Ralph Lazzara; C A Sivaram
Journal:  Echocardiography       Date:  2008-05-07       Impact factor: 1.724

4.  Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.

Authors:  L J Ayash; J E Wright; O Tretyakov; R Gonin; A Elias; C Wheeler; J P Eder; A Rosowsky; K Antman; E Frei
Journal:  J Clin Oncol       Date:  1992-06       Impact factor: 44.544

5.  Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group.

Authors:  J N Cohn; G Johnson
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

6.  Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology.

Authors:  F A Bu'Lock; M G Mott; A Oakhill; R P Martin
Journal:  Br Heart J       Date:  1995-04

7.  Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant.

Authors:  B Hertenstein; M Stefanic; T Schmeiser; M Scholz; V Göller; M Clausen; D Bunjes; M Wiesneth; J Novotny; M Kochs
Journal:  J Clin Oncol       Date:  1994-05       Impact factor: 44.544

8.  Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations.

Authors:  B Cazin; N C Gorin; J P Laporte; B Gallet; L Douay; M Lopez; A Najman; G Duhamel
Journal:  Cancer       Date:  1986-05-15       Impact factor: 6.860

9.  Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.

Authors:  Samo Zver; Vesna Zadnik; Matjaz Bunc; Polona Rogel; Peter Cernelc; Mirta Kozelj
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490

10.  Subacute anthracycline cardiotoxicity.

Authors:  Christopher L Hengel; Prudence A Russell; Paul A Gould; David M Kaye
Journal:  Heart Lung Circ       Date:  2005-11-11       Impact factor: 2.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.